ArticleDiscover oncology2023

Identification and verification of an ALYREF-involved 5-methylcytosine based signature for stratification of prostate cancer patients and prediction of clinical outcome and response to therapies.

Xiao Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.